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Introduction {#sec001}
============

Intravenous thrombolysis (IVT) is one of the most efficacious treatments for acute ischemic stroke (AIS), for which therapeutic intervention is highly time-sensitive \[[@pone.0154972.ref001],[@pone.0154972.ref002],[@pone.0154972.ref003]\]. Less than half of American \[[@pone.0154972.ref004]\] and even fewer Chinese \[[@pone.0154972.ref005],[@pone.0154972.ref006]\] patients with AIS are treated with recombinant tissue plasminogen activator within the time frame recommended by the American Heart Association and American Stroke Association \[door-to-needle (DTN) time ≤ 60 min\] \[[@pone.0154972.ref007]\], which has been validated by the Get With The Guidelines---Stroke program \[[@pone.0154972.ref008]\]. Facilitating the process of IVT may improve the rate of DTN time ≤ 60 min and consequently, IVT patient prognosis \[[@pone.0154972.ref004],[@pone.0154972.ref009],[@pone.0154972.ref010],[@pone.0154972.ref011],[@pone.0154972.ref012]\].

Although strategies for reducing in-hospital delays of IVT administration have been implemented in many Western institutions \[[@pone.0154972.ref004],[@pone.0154972.ref009],[@pone.0154972.ref010],[@pone.0154972.ref011],[@pone.0154972.ref012]\] and the median DTN time has been reduced to \< 20 min in at least one stroke center \[[@pone.0154972.ref010]\], this has not been the case in most Chinese hospitals \[[@pone.0154972.ref005],[@pone.0154972.ref006]\], which may be attributed to differences between the Chinese healthcare system and those of Western countries \[[@pone.0154972.ref013]\]. Our previous study showed that the main causes of delays in DTN time were the time taken for decision-making and laboratory tests \[[@pone.0154972.ref006]\]. In the present historical controlled study, we investigated the efficacy and safety of various strategies for reducing DTN time at a tertiary hospital in China.

Methods {#sec002}
=======

Ethics statement {#sec003}
----------------

The study protocol was approved by the Ethical Committee of Xuanwu Hospital, and conforms to the principles outlined in the Declaration of Helsinki. Written, informed consent was obtained from all patients.

Participant eligibility and enrollment {#sec004}
--------------------------------------

The Generalization of the Right Acute Stroke Prevention Strategies (GRASPs) program for reducing in-hospital delay was initiated at the end of 2014. The main items of this program included a systematic literature review, analysis of factors contributing to in-hospital delays at our hospital, and a multilevel implementation strategy that integrated currently available resources and methods for selecting IVT candidates ([Fig 1](#pone.0154972.g001){ref-type="fig"}). The following primary data from the literature review were noted: improvements related to emergency medical services \[[@pone.0154972.ref004],[@pone.0154972.ref009],[@pone.0154972.ref010],[@pone.0154972.ref011],[@pone.0154972.ref014]\], emergency departments \[[@pone.0154972.ref004],[@pone.0154972.ref009],[@pone.0154972.ref010]\], radiology departments \[[@pone.0154972.ref004],[@pone.0154972.ref009],[@pone.0154972.ref010],[@pone.0154972.ref014],[@pone.0154972.ref015]\], and laboratories \[[@pone.0154972.ref010],[@pone.0154972.ref016]\]; public education programs \[[@pone.0154972.ref017]\]; and other organizational changes in the stroke treatment protocol \[[@pone.0154972.ref004],[@pone.0154972.ref010],[@pone.0154972.ref012],[@pone.0154972.ref018],[@pone.0154972.ref019]\]. Existing features at our hospital included a neurological unit inside the emergency department, a stroke team and stroke unit on call 24/7, and protocols for emergency endovascular treatment, critical care, and rehabilitation of AIS patients.

![Flow chart of the GRASPs study for reducing in-hospital delays.](pone.0154972.g001){#pone.0154972.g001}

AIS patients who visited our hospital through 2015 were recruited as the post-intervention group after the improvement program was implemented in January 2015. The published data for patients enrolled between March 2011 and December 2014 was taken as a historical control (pre-intervention group). And all the AIS cases treated with IVT in 2015 were collected prospectively as the post-intervention group \[[@pone.0154972.ref006]\]. AIS diagnostic and treatment protocols have been previously described in detail \[[@pone.0154972.ref006]\], and were slightly modified after the April 2015 update of Chinese guidelines for the care for AIS \[[@pone.0154972.ref020]\]. In short, the limit of upper age (80 years) and mild stroke severity were removed from exclusions of IVT in the updated guideline \[[@pone.0154972.ref020]\]. Conferences were held weekly in order to monitor the efficiency of the stroke treatment protocol. The STROBE Statement that should be included in reports of cohort studies was followed ([S1 STROBE Checklist](#pone.0154972.s001){ref-type="supplementary-material"}).

Explanatory and outcome variables {#sec005}
---------------------------------

Information such as demographic data, stroke severity \[as measured by the National Institutes of Health Stroke Scale (NIHSS)\], baseline blood pressure and sugar level, medical history of vascular diseases, smoking and drinking status, drug history, and additional factors that were likely to be associated with in-hospital delays \[pre-notification from emergency system, urgent blood pressure management, multi-model head imaging, concurrent transient ischemic attack (TIA) or rapidly improving symptoms (RIS)\], lesion sites (classified as anterior and posterior circulation according to magnetic resonance imaging results), and admission date and hour were noted \[[@pone.0154972.ref006]\]. Mild stroke (including RIS) were defined as baseline NIHSS ≤ 3. Outcomes such as neurological improvement (measured as NIHSS), mortality, and systemic intracranial hemorrhage (SICH) at discharge were also recorded. Adverse events related to rapid administration of alteplase, serious bleeding complications for not waiting laboratory results, and erroneous thrombolytics administration for stroke mimics were also recorded. Neurological improvement (NI) at discharge was defined as NIHSS = 0 from a mild baseline (score ≤ 3), improvement by ≥ 4 from a moderate baseline NIHSS (score of 4--9), or improvement by ≥ 8 from a severe baseline NIHSS (score ≥ 10). SICH was defined as any clinical deterioration in NIHSS accompanied by hemorrhage in the 24--36 h after a computed tomography (CT) scan following IVT.

The rate of DTN time ≤ 60 min was set as the primary endpoint, consistent with criteria of the American Stroke Association Target---Stroke initiative \[[@pone.0154972.ref004]\]. Changes in other parameters, including onset-to-door (OTD), door-to-examination (DTE), door-to-imaging (DTI), door-to-laboratory (DTL), and final-test-to-needle (FTN) times, rates of onset-to-needle (OTN) time ≤ 180 min, and NI at discharge (measured as NIHSS) were set as secondary outcomes. FTN was used to identify the time interval from the last screening test to the needle time of IVT, which included the communication process for IVT decision-making and was equal to 0 when the decision was made before the last test was completed. Mortality and SICH at discharge served as safety indicators.

Statistical analysis {#sec006}
--------------------

Statistical analyses were carried out with SPSS v.17.0 software. Continuous variables are presented as median and interquartile range (IQR), and categorical data as percentage (%). The Mann-Whitney U and χ^2^ tests were used to compare related variables between groups, and a two-tailed P-value \< 0.05 was considered statistically significant. Multivariable linear regression analysis was performed in order to identify factors contributing to DTN time \> 60 min in the post-intervention group, in which variables were selected from the univariate analysis at a significance level ≤ 0.20.

Results {#sec007}
=======

Patient characteristics {#sec008}
-----------------------

A total of 348 IVT cases (202 and 146 in the pre- and post-intervention groups, respectively) were recruited for the study. The median age was 61 years (IQR: 52--68 years), and 25.2 and 26.7% of patients were female in the pre- and post-intervention groups, respectively. Demographic and other characteristics of the two groups are shown in [Table 1](#pone.0154972.t001){ref-type="table"}. The post-intervention group showed higher rates of dyslipidemia and minor stroke (defined as NIHSS ≤ 3) and less frequent atrial fibrillation; had a greater number of current smokers, heavy drinkers, referrals, and cases that required multi-model head imaging (all P \< 0.05); and lower median NIHSS (score = 4 vs. 9; P \< 0.001) and blood sugar level (6.4 vs. 6.9 mmol/l; P = 0.020). The differences in rates among older patients (age ≥ 80 years) did not reach statistical significance (P = 0.878). In 17/146 (11.6%) of IVT cases, pre-notification signals were sent prior to patient admission.

10.1371/journal.pone.0154972.t001

###### Baseline characteristics of cases included in this study[\*](#t001fn001){ref-type="table-fn"}.

![](pone.0154972.t001){#pone.0154972.t001g}

                                                 Acute ischemic stroke patients treated with IVT                       
  -------------------------- ------------------- ------------------------------------------------- ------------------- ---------
  Age,years,                 61 (52--68)         61 (51--69)                                       61 (53--68)         0.633
   Age ≥80 years             9 (2.6)             5 (2.5)                                           4 (2.7)             0.878
  Female                     90 (25.9)           51 (25.2)                                         39 (26.7)           0.758
  Medical history                                                                                                      
   Hypertension              215 (61.8)          122 (60.4)                                        93 (63.7)           0.532
   Diabetes                  106 (30.5)          55 (27.2)                                         51 (34.9)           0.123
   Dyslipidemia              150 (43.1)          75 (37.1)                                         75 (51.4)           0.008
   CHD                       56 (16.1)           30 (14.9)                                         26 (17.8)           0.459
   AF                        44 (12.6)           32 (15.8)                                         12 (8.2)            0.035
   Prior stroke              77 (22.1)           39 (19.3)                                         38 (26.0)           0.136
   Current smoke             166 (47.7)          111 (55.0)                                        55 (37.7)           0.001
   Heavy drinking            100 (28.7)          69 (34.2)                                         31 (21.2)           0.009
  NIHSS                      7 (4--12)           9 (5--12)                                         4 (3--11)           \<0.001
   The rate of NIHSS≤3       60 (17.2)           10 (5.0)                                          50 (34.2)           \<0.001
  Baseline variables                                                                                                   
   SBP(mmHg)                 150 (130--165)      150 (130--165)                                    150 (135--169)      0.383
   DBP(mmHg)                 85 (80--95)         85 (80--92)                                       88 (80--96)         0.286
   Blood sugar (mmol/l)      6.7 (5.7--8.6)      6.9 (5.8--8.7)                                    6.4 (5.4--7.8)      0.020
   BMI(kg/m^2^)              25.4 (23.5--27.5)   25.0 (23.2--27.4)                                 25.4 (23.9--27.6)   0.214
  Other variables                                                                                                      
   Urgent management of BP   40 (11.5)           27 (13.4)                                         13 (8.9)            0.198
   Present as TIA            55 (15.8)           29 (14.4)                                         26 (18.3)           0.384
   Referral                  106 (30.5)          70 (34.7)                                         36 (24.7)           0.046
   Transferring with EMS     175 (50.3)          101 (50.0)                                        74 (50.7)           0.900
   Pre-notification          17 (3.2)            0 (0)                                             17 (11.6)           \<0.001
   Lesion in AC              282 (81.0)          167 (82.7)                                        115 (78.8)          0.428
   Multi-model imaging       65 (18.7)           59 (29.2)                                         6 (4.1)             \<0.001
   Medical insurance         208 (59.8)          113 (55.9)                                        95 (65.1)           0.087
   Working days              246 (70.7)          147 (72.8)                                        99 (67.8)           0.315
   Working hours             191 (54.9)          114 (56.4)                                        77 (52.7)           0.494

\*Unless otherwise stated, continuous and categorical data are presented as median (IQR) and percentage (%), respectively, with P-values calculated using Mann-Whitney U and χ^2^ tests, respectively.

AC, anterior circulation; AF, atrial fibrillation; BMI, body mass index; BP, blood pressure; CHD, coronary heart disease; DBP, diastolic blood pressure; IQR, interquartile range; IVT, intravenous thrombolysis; NIHSS, National Institutes of Health Stroke Scale; RIS, rapidly improving symptoms; SBP, systolic blood pressure; TIA, transient ischemic attack.

All time intervals except OTD were reduced by the intervention (P \< 0.05); the net improvement for DTN, DTE, DTI, DTL, and FTN were 63, 2, 4, 28, and 23 min, respectively ([Table 2](#pone.0154972.t002){ref-type="table"}). Improvements were observed in the rates of DTN time ≤ 60 min (pre: 9.9% vs. post: 60.3%; P \< 0.001) and OTN time ≤ 180 min (pre: 23.3% vs. post: 53.4%; P \< 0.001). Only 33/146 (22.6%) achieved a DTN time ≤ 40 min. The post-intervention group also showed a higher rate of NI (pre: 45.5% vs. post: 59.6%; P = 0.010), but there were no differences in SICH (P = 0.091) or mortality (P = 0.875) at discharge. One case with symptoms that mimicked those of stroke was thrombolyzed, with a final diagnosis of acute clozapine poisoning. There were no serious hemorrhagic complications as a result of not waiting for time-consuming laboratory tests.

10.1371/journal.pone.0154972.t002

###### Time intervals and outcomes of cases included in this study[\*](#t002fn001){ref-type="table-fn"}.

![](pone.0154972.t002){#pone.0154972.t002g}

                                 Pre-intervention(n = 202)   Post-intervention(n = 146)   *P*
  ------------------------------ --------------------------- ---------------------------- ---------
  OTD(min)                       110 (67--164)               106 (67--140)                0.510
  DTN(min)                       116 (93--135)               53 (43--86)                  \<0.001
  The rate of DTN≤60min (%)      20 (9.9)                    88 (60.3)                    \<0.001
   OTN(min)                      229 (185--270)              173 (130--225)               \<0.001
    The rate of OTN≤180min (%)   47 (23.3)                   78 (53.4)                    \<0.001
   DTE(min)                      10 (6--15)                  8 (4--13)                    \<0.001
   DTI(min)                      28 (15--40)                 24 (16--29)                  0.002
   DTL(min)                      84 (67--103)                56 (45--73)                  \<0.001
   FTN(min)                      27 (11--45)                 4 (0--24)                    \<0.001
  Neurological improvement       92 (45.5)                   87 (59.6)                    0.010
  Mortality                      9 (4.5)                     6 (4.1)                      0.875
  SICH                           7 (3.5)                     11 (7.5)                     0.091

\*Data are presented as median (IQR) or percentage (%); P-values were calculated using Mann-Whitney U and χ^2^ tests for continuous and categorical variables, respectively.

DTE, door-to-examination time; DTI, door-to-imaging time; DTL, door-to-laboratory time; DTN, door-to-needle time; FTN, final-test-to-needle time; IQR, interquartile range; OTD, onset-to-door time; OTN, onset-to-needle time; SICH, symptomatic intracranial hemorrhage.

There were no statistical differences in baseline characteristics in the post-intervention group, except for the rate of cases with multi-model head imaging between subgroups with or without in-hospital delay ([S1 Table](#pone.0154972.s002){ref-type="supplementary-material"}). All six cases (4.1%) with multi-model head imaging experienced in-hospital delays, while 17 (11.6%) with pre-notification before admission were treated by IVT without in-hospital delays. Significant improvements in time intervals (DTE, DTI, DTL, and FTN) were also observed in the subgroup without in-hospital delays, although there was no statistical significance in outcome measures ([Table 3](#pone.0154972.t003){ref-type="table"}). Six variables (OTD, DTE, DTI, DTL, FTN, and multi-model imaging) with P ≤ 0.20 in the univariate analysis ([S2 Table](#pone.0154972.s003){ref-type="supplementary-material"}) were included in multivariate linear regression models, of which FTN (P \< 0.001), DTL (P \< 0.001), and with multi-model imaging (P = 0.032) were significantly associated with in-hospital delays post-intervention ([Table 4](#pone.0154972.t004){ref-type="table"}). Details of factors influencing in-hospital delays post-intervention are shown in [Fig 1](#pone.0154972.g001){ref-type="fig"}.

10.1371/journal.pone.0154972.t003

###### Time intervals and outcomes of cases in the post-intervention group[\*](#t003fn001){ref-type="table-fn"}.

![](pone.0154972.t003){#pone.0154972.t003g}

                             DTN ≤60min (n = 88)   DTN \>60min (n = 58)   *P*
  -------------------------- --------------------- ---------------------- ---------
  OTD (min)                  110 (76--157)         100 (58--129)          0.073
  DTN (min)                  45 (36--52)           98 (79--122)           \<0.001
  OTN (min)                  148 (115--201)        206 (146--245)         \<0.001
  DTE (min)                  6 (3--10)             12 (6--15)             \<0.001
  DTI (min)                  22 (12--28)           27 (20--30)            0.003
  DTL (min)                  51 (43--61)           72 (55--83)            \<0.001
  FTN (min)                  0 (0--5)              26 (11--37)            \<0.001
  Neurological improvement   53 (60.2)             34 (58.6)              0.847
  Mortality                  2 (2.3)               4 (6.9)                0.168
  SICH                       7 (8.0)               4 (6.9)                0.813

\*Data are presented as median (IQR) or percentage (%). P-values for continuous and categorical variables were calculated with the Mann-Whitney U and χ^2^ tests, respectively.

DTE, door-to-examination time; DTI, door-to-imaging time; DTL, door-to-laboratory time; DTN, door-to-needle time; FTN, final-test-to-needle time; IQR, interquartile range; OTD, onset-to-door time; OTN, onset-to-needle time; SICH, symptomatic intracranial hemorrhage.

10.1371/journal.pone.0154972.t004

###### Multivariate linear regression analysis of independent variables affecting in-hospital delays post-intervention[\*](#t004fn001){ref-type="table-fn"}.

![](pone.0154972.t004){#pone.0154972.t004g}

  Variables                   Standardized coefficient   *P*
  --------------------------- -------------------------- ---------
  Onset-to-door time          -0.041                     0.529
  Door-to-evaluation time     -0.006                     0.949
  Door-to-imaging time        0.091                      0.218
  Door-to-laboratory time     0.336                      \<0.001
  Final-test-to-needle time   0.480                      \<0.001
  CT perfusion imaging        0.140                      0.032
  Pre-notification            -0.139                     \<0.001

\*In-hospital delays were defined as DTN times \> 60 min.

Discussion {#sec009}
==========

It is important to design a multi-level implementation strategy for reducing in-hospital delays of IVT administration that fits the specific organization. To our best knowledge, this is the first report that incorporates experiences from more advanced institutions and progressive self-reform in Chinese hospitals. Our study showed that it is possible to achieve a DTN time of ≤ 60 min at as many as 60% of hospitals in the Chinese healthcare system---and thereby improve the short-term prognosis of IVT cases---by implementing organizational changes.

Reducing delays in DTL and FTN times contributed the most to the improvement in DTN time at our hospital. We identified specific factors causing time delays and limiting accessibility to IVT in our earlier studies \[[@pone.0154972.ref006],[@pone.0154972.ref021]\], which allowed us to target our improvement efforts. The best practices from other studies \[[@pone.0154972.ref014],[@pone.0154972.ref022],[@pone.0154972.ref023]\] as well as from our own previous work \[[@pone.0154972.ref006]\] included simplifying as much as possible the items in screening tests (including simplified blood biochemical tests and a single CT scan for head imaging), not waiting for formal laboratory reports for patients without related history, and negotiating with IVT candidates using reserve protocols and tools (e.g., informed outcome diagrams for IVT). As highlighted in the TARGET: STROKE trial protocol \[[@pone.0154972.ref024]\], implementing organizational changes requires highly coordinated, multilevel, and focused effort. The success of GRASPs was also attributed to the coordinated efforts of all related departments, including but not limited to the neurology and neurosurgery departments. A clear target in the DTN time frame and a prompt data feedback system were invaluable in facilitating cooperation in the IVT candidate selection protocol.

However, there remain shortcomings in the Chinese hospital network as compared to more advanced institutions \[[@pone.0154972.ref009],[@pone.0154972.ref010],[@pone.0154972.ref014]\]. The main problems were difficulty in implementing a round-the-clock point-of-care laboratory test with sufficient staff and other resources, a low rate of pre-notifications from EMS, and delayed activation of the system for fully loaded neurologists and nurses in the emergency department. Less familiarity with stroke symptoms, especially in cases of mild stroke, may have contributed to DTI time delays in our study; to this end, training programs in stroke symptom recognition for emergency physicians, nurses, and radiologists could be helpful \[[@pone.0154972.ref013]\]. However, even well-designed randomized controlled trials with a fixed implementation strategy may achieve only mild-to-moderate progress in promoting IVT for AIS \[[@pone.0154972.ref025],[@pone.0154972.ref026]\]. Modern guidelines with detailed recommendations for reducing IVT time delays, national stroke initiative programs (e.g., the TARGET: STROKE trial \[[@pone.0154972.ref004],[@pone.0154972.ref024]\]), and effective monitoring protocols for stroke care are still needed in China.

Recently, programs for reducing in-hospital delays were explored in highly developed hospitals equipped with the modern technologies and skilled staff. Mobile stroke treatment units are now available in Germany and the USA \[[@pone.0154972.ref027],[@pone.0154972.ref028]\], which could potentially minimize in-hospital delays for IVT candidates. However, due to the unavailability of specialized equipment and other problems unique to the Chinese healthcare system \[[@pone.0154972.ref013]\], such units may not be realistic for most of Chinese hospitals at present. On the other hand, pre-hospital factors merit greater attention \[[@pone.0154972.ref029]\] and may also contribute to the reduction in IVT treatment time delays \[[@pone.0154972.ref018]\].

Our study had some limitations. Firstly, the experiences of a single hospital may not apply to other institutions. However, the positive results of the GRASPs study provide a basis for self-reform at other hospitals. Moreover, we were unable to draw a firm conclusion such as that of the Target: Stroke initiative \[[@pone.0154972.ref004]\], since not all endpoints (e.g., mortality and SICH) were improved following the intervention, possibly due to the relatively small sample size.

Conclusions {#sec010}
===========

Our study demonstrated favorable results in GRASPs for reducing in-hospital delays in IVT treatment. Organizational changes were accompanied by significant improvements in patient outcome.
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